Diana G. Eng
- Molecular Biology top 5%
- Nephrology top 1%
- Pharmacology top 5%
- Genetics
- Biomedical Engineering
- Co-authors
- Jeffrey W. PippinStuart J. ShanklandNatalya KaverinaJay D. KeaslingJack D. NewmanChristopher J. PaddonTizita HorningHiroko Tsuruta
- Topics
- Renal Diseases and Glomerulopathies (20 papers)Renal and related cancers (15 papers)Chronic Kidney Disease and Diabetes (14 papers)
- Partner nations
- United StatesSingaporeJapan
In The Last Decade
Diana G. Eng
40 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Molecular Biology 1.4k
- Nephrology 487
- Pharmacology 321
- Genetics 170
- Biomedical Engineering 147
Countries citing papers authored by Diana G. Eng
This map shows the geographic impact of Diana G. Eng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana G. Eng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana G. Eng more than expected).
Fields of papers citing papers by Diana G. Eng
This network shows the impact of papers produced by Diana G. Eng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana G. Eng. The network helps show where Diana G. Eng may publish in the future.
Co-authorship network of co-authors of Diana G. Eng
This figure shows the co-authorship network connecting the top 25 collaborators of Diana G. Eng. A scholar is included among the top collaborators of Diana G. Eng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana G. Eng. Diana G. Eng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 8 | |
| 4 | 16 | |
| 5 | 44 | |
| 6 | 47 | |
| 7 | 83 | |
| 8 | 0 | |
| 9 | 39 | |
| 10 | 22 | |
| 11 | 18 | |
| 12 | 48 | |
| 13 | 105 | |
| 14 | 14 | |
| 15 | Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisininbreakdown → | 551 |
| 16 | 13 | |
| 17 | 7 | |
| 18 | 278 | |
| 19 | 151 | |
| 20 | Tumor response to interferon inducer and radiation effect of serum interferon levels. | 3 |
About Diana G. Eng
Diana G. Eng is a scholar working on Nephrology, Aging and Genetics, having authored 43 papers that have together received 1.9k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (20 papers), Renal and related cancers (15 papers) and Chronic Kidney Disease and Diabetes (14 papers). The work is most often cited by research in Nephrology (487 citations), Molecular Biology (1.4k citations) and Pharmacology (321 citations). Diana G. Eng has collaborated with scholars based in United States, Singapore and Japan. Frequent co-authors include Jeffrey W. Pippin, Stuart J. Shankland, Natalya Kaverina, Jay D. Keasling, Jack D. Newman, Christopher J. Paddon, Tizita Horning, Hiroko Tsuruta, Rika Regentin and Neil S. Renninger. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.